{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/headache-medication-overuse/background-information/definition/","result":{"pageContext":{"chapter":{"id":"3d866153-0662-5ce8-b955-3970472be336","slug":"definition","fullItemName":"Definition","depth":2,"htmlHeader":"<!-- begin field 8b4b74a3-633b-4729-b3b6-e8a187224457 --><h2>What is it?</h2><!-- end field 8b4b74a3-633b-4729-b3b6-e8a187224457 -->","summary":"","htmlStringContent":"<!-- begin item 702ef849-5415-4ff1-8484-dea8fba3397e --><!-- begin field 83d27ec6-b625-4ffc-9211-608598896131 --><ul><li><strong>Medication overuse headache is a chronic headache</strong> which results from, and is perpetuated by, overuse of acute or symptomatic headache medications such as triptans, opioids, nonsteroidal anti-inflammatories (NSAIDs) and paracetamol.<ul><li>The headache usually (but not always) resolves following cessation of the overused medication — withdrawal may cause the headache to worsen initially.</li><li>Simple analgesics (alone or in combination with caffeine) are the most frequently overused drugs followed by triptans.</li></ul></li><li><strong>The International Classification of Headache Disorders</strong> states that medication overuse headache can be diagnosed if:<ul><li>Headache occurs on 15 or more days per month as a result of regular overuse of acute and/or symptomatic headache medication for more than 3 months in a person with a pre-existing headache disorder.<ul><li>For ergotamine, triptans, opioids and combination analgesics intake must be 10 days or more per month to be considered overuse.</li><li>For simple analgesics such as NSAIDs (including aspirin) and paracetamol intake must be 15 days or more per month to be considered overuse.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Johnson, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">IHS, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Katsarava, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Da Silva, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Kristoffersen, 2014a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Green, 2016</a>]  </p><!-- end field 83d27ec6-b625-4ffc-9211-608598896131 --><!-- end item 702ef849-5415-4ff1-8484-dea8fba3397e -->","topic":{"id":"c3e2af9a-7e39-5197-9eb3-1ed7a0e55408","topicId":"876b21f6-c785-4745-8233-2a56adca5e2f","topicName":"Headache - medication overuse","slug":"headache-medication-overuse","lastRevised":"Last revised in November 2017","chapters":[{"id":"40857afc-808e-588e-8df4-4d8b15ec657a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"63871d8d-20ed-5111-b909-c671b7d8290d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9cae9867-86cc-59c4-b6bf-f373dcba4164","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8249aff5-50e4-5d82-9408-80a413334b35","slug":"changes","fullItemName":"Changes"},{"id":"db547c32-5bee-554a-a0b2-dc3586cf0545","slug":"update","fullItemName":"Update"}]},{"id":"2abe896d-4027-5ea6-b53c-4126bd2728c4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"38f0d3b1-709d-5342-b729-a1341e432308","slug":"goals","fullItemName":"Goals"},{"id":"a38c1ab1-09de-5ef7-baff-841d15605039","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"43907ef2-b709-5ebe-b83b-ab23bc9ed6ca","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"0feb34c0-feb0-5b65-a4c1-32baeee2a780","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"dd0c4d51-1d5a-5ed5-913d-c4891dbdcdad","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5b6a60a6-ec80-5422-af6f-b6397fc4eb49","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"3cd81fd7-0d7a-552d-84fc-71226d45fd89","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3d866153-0662-5ce8-b955-3970472be336","slug":"definition","fullItemName":"Definition"},{"id":"d33eb885-20a8-5803-a999-aceb7adffb72","slug":"causes","fullItemName":"Causes"},{"id":"f8475e5f-a2f9-5002-932a-d7ba4870aa9f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a1c40b6b-4520-56e8-b2fa-bb765751e34f","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"b50624f5-1fc7-5aae-8abf-9c5d20c25996","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c264e53b-3cbc-5157-819e-b2829d10ddf3","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"7a8b4459-1ea1-567d-894f-eee914a8f3e0","slug":"assessment","fullItemName":"Assessment"},{"id":"0fffe194-2a62-5cc8-921c-70edbfaaee2f","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"24bded00-bd1c-5e35-8d9e-e9cbdb170491","fullItemName":"Management","slug":"management","subChapters":[{"id":"5aa2d427-7d2b-5110-b3c3-149b3c9ae20f","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"2d1b86f8-d377-5c3d-9334-138f4cdb5622","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"e8ea0b38-7c95-5427-8107-b6506325dd95","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"83630e7e-e220-5043-af84-8cf6a05f13d4","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9d829e6b-790e-5c8c-b792-58adea1a2dd3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7de26ebd-eda1-5880-8547-e657d94fc6a0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e74b3fd8-6eac-5d2e-886c-97583955d536","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3ce1ab25-89c2-5795-9e6a-493771574210","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"78c55256-334c-5f3e-8d0f-80013fc16bc9","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"3cd81fd7-0d7a-552d-84fc-71226d45fd89","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}